Gnosis’ Report unveils High Stability of vitaMK7®: natural IS MORE stable

December, 16th 2016

Gnosis vitaMK7® is produced through a unique and innovative industrialization method to deliver natural, stable, high purity (>99% pure) Vitamin K2 as MK7 from fermentation, in order to resemble the natural occurring Vitamin K2 present in the Japanese natto food...

 

A new achievement by Gnosis and our MKT team

December, 12th 2016

Gnosis is proud to announce that from now on our tools are also available in two other different languages: Chinese and Russian...

 

The 24th Annual World Congress on Anti-Aging Medicine is coming!

December, 2nd 2016

From December 9th to 11th, for the first time Gnosis will exhibit at the American Academy of Anti-Aging Medicine Congress with Quatrefolic, VitaMK7, Adomet and Biooptima...

 

Gnosis listed in the Certified Companies of Halal International Authority (HIA)

November, 24th 2016

We are proud to inform our partners and customers that both of ours Manufacturing Operations - Gnosis Bioresearch SA (Sant'Antonino - CH) and Gnosis Bioresearch Srl (Pisticci – Italy) - have been listed in the Certified Companies of Halal International Authority (HIA), the independent organization which since 2010 has become the Halal Certification Authority recognized on an international scale...

 

New study shows significant effect of Quatrefolic® in lowering Homocysteine Serum Levels

November, 10th 2016

A recently new published study has investigated the efficacy of Quatrefolic® in lowering homocysteine serum levels (HCys) versus a conventional vitamin supplementation with highly dosed folic acid (5 mg/day) in hypertensive subjects at low cardiovascular risk...

 

Vitamin K2 stands in the front rank for nutrients at World Osteoporosis Day

October, 27th 2016

On the occasion of the World Osteoporosis Day which takes place every year on October 20th, Gnosis has participated at the special event "Supplements in the non-pharmacologic treatment of osteoporosis" with a speech held by Dr. Luca Tiano...

 

ConsumerLab seals of approval for supplements with folate

October, 24th 2016

The importance of the consumption of folate to support the body's well-being is now widely recognized and folate definitely represents one of the most common nutritional ingredients used during all stages of life...

 

Enthusiastic feed-back of nutraceutical industry at VENDORBRIEF speech on Mythocondro®

October, 21st 2016

In the last weeks, a great curiosity and an expectable enthusiasm have been felt about the speech organized by Gnosis in the Education Session of the VENDORBRIEF Presentation at Supply Side West, on the new non-animal chondroitin sulfate branded Mythocondro®...

 

Overwhelming success of Gnosis at Supply Side West and CPhI

October, 13th 2016

Overwhelming success of Gnosis in October which took part at two key and concurrent events, the CPhI - the leading European pharmaceutical exhibition held in Barcelona - and the SupplySide West - one of the world's leading ingredient and solutions tradeshow of nutraceutical industry, held in Las Vegas...

 

Gnosis welcomes you at CPhI 2016, "The Worldwide Pharma Exhibition"

September, 29th 2016

Gnosis will be exhibiting at CPhI Worldwide, which will be held in Barcelona from 4th to 6th October. CPhI is the leading European pharmaceutical exhibition, the core meeting point of the global pharmaceutical community where to discuss business opportunities and stay tuned on market news and trends...

 

Mythocondro® Vendorbrief Presentation at Supply Side West

September, 22nd 2016

Supply Side West is approaching and we will be protagonist with the launch of Mythocondro®, the first Non-Animal Chondroitin sulfate of fermentation origin, that promises to change completely the CS industry...

 

Gnosis Quatrefolic® earns approval in Australia by TGA

September, 2nd 2016

Gnosis is proud to announce that on August 9th, 2016 Quatrefolic® (Levomefolate glucosamine or also (6S)-5-MTHF glucosamine salt), the biologically active form of the naturally-occurring predominant form of folate, has been approved as permitted ingredient for listed medicines by TGA...

 

Gnosis… an Italian player in the global healthcare market

August, 30th 2016

Read about Gnosis in the report "Italy Healthcare and Life Sciences Review 2016" that will provide an updated and thorough insight into the Italian Healthcare & Pharmaceutical sector...

 

Quatrefolic® and Adomet®: Depression Focus

July, 12th 2016

Low folate concentrations have been associated with both an increased incidence of depression and an inadequate response to treatment...

 

CPHi China 2016: another great success for Gnosis

July, 11th 2016

For the first time ever, Shanghai saw Gnosis exhibiting at CPHI - Healthplex & Nutraceutical China 2016, June 21-23...

 

MK7 Standards Reference: a brand-new section for vitaMK7® website

June, 20th 2016

The high success of Vitamin K2 menaquinone-7 in several markets, and the recognition of tangible benefits of its supplementation, stated the matter of recognized common standards of the ingredient both from manufacturer of finished products and end-users...

 

XaQuilXR with Quatrefolic® is the Finished Product of the Year - Medical Food category at the NutraIngredients Awards 2016

May, 17th 2016

Gnosis is proud to announce that its commitment to providing innovative solutions to global well-being and health care challenges has been rewarded at NutraIngredients Award 2016, winning in the FINISHED PRODUCT OF THE YEAR - medical food category...

 

This year Vitafoods sees Gnosis protagonist!

May, 4th 2016

Vitafoods, the global nutraceutical event, is arriving in Geneva, May 10th – 12th, and Gnosis will be there with lot of news and innovations...

 

Adomet® White Paper disclosures Gnosis' "body of knowledge" of SAMe, the most active methyl donor in human body

May, 3rd 2016

Gnosis is really excited to announce the publication of Adomet® White Paper, an essential communication tool that can help our customers and readers to know more about Gnosis’ branded SAMe [S-adenosyl-methionine] product...

 

Welcome to the brand-new Quatrefolic® website!

May, 2nd 2016

2016 sees Quatrefolic® keep collecting achievements, establishing itself in the entire global market as the benchmark for the whole industry of folate derivatives...

 

Vitafoods time! Gnosis more and more in the limelight

April, 18th 2016

The global nutraceutical event is growing each time and this year is no exception. The nutraceutical business meets in Geneva on May 10th through 12th...

 

Quatrefolic® in partnership with Xymogen is short-listed for NutraIngredients Awards 2016!

April, 7th 2016

The partnership between Gnosis and the US nutraceutical producer Xymogen is proving successful! Xymogen's XaQuilXR, finished product that contains Gnosis' Quatrefolic®, has been selected...

 

Japan's Ministry of Health Grants Osteoarthriris Health Claim for SAMe Superesse®

March, 14th 2016

Gnosis is truthfully proud to announce a great confirmation and success obtained from Superesse®, the enriched natural yeast with S-Adenosylmethionine (SAMe)...

 

Gnosis vitaMK7® earns Novel Food Approval in Brazil by ANVISA

March, 4th 2016

Gnosis is delighted to announce that on February 22nd, 2016 the Brazilian National Health Surveillance Agency, ANVISA, has approved the use of vitaMK7®, the Natural Vitamin K2 as MK7...

 

Quatrefolic® approved by Ministry of Health of the People’s Republic of China

March, 2nd 2016

Gnosis is pleased to announce that on February 16th, 2016 Quatrefolic®, the biologically active form of the naturally-occurring predominant form of folate, has been approved...

 

Gnosis exhibits at “Integrative Healthcare symposium conference”: is this a new concept of “Innovative nutraceutical supplier”?

February, 17th 2016

Recent startling progress in life science research herald new developments in food, nutrition and health and are, today as in the past, the stimulus to Gnosis to create the wide range of products...

 

A 2016 newborn: Gnosis’ Advanced Information Newsletter!

February, 2nd 2016

A brand-new newsletter has been released by Gnosis! Advanced Information Newsletter is our commitment to increase Gnosis-to-customer communication...

 

VitaMK7® new Chinese website release is now out!

January, 25th 2016

Gnosis is proud to announce the release of a new vitaMK7® - Chinese version - website, which goes live today and is located at the new web address: www.vitamk7.com/cn/index.php...

 

Gnosis further affirmation on folates

January, 8th 2016

Gnosis is pleased to report that the Federal Circuit Court of Appeals has agreed with the U.S. Patent Office that all of the patent claims that it challenged are invalid as obvious...

 

< Turn back

 

 

 

 

GNOSIS S.P.A. Sede Legale: Piazza del Carmine, 4 20121 Milano. P. IVA 02484720129 C. F. 10197170151 Cap. Soc. 3.000.000,00 € i.v. Registro delle imprese di Milano N° 10197170151